Sell Your Science: Best Practices for Developing an Effective Non-Confidential Pitch Deck
It can be tricky to communicate the full potential of your discoveries without spilling the secret sauce. Join us for a session on learning the tricks of the trade in preparing a non-confidential deck and executive summary. An expert of the craft will share practical tips on becoming more effective in communicating your story to investors, increasing your chances of successful fundraising.
This workshop is ideal for inventors in academic centers and hospitals, and early stage healthcare start-ups in the pharma, medical device, consumer health and digital innovation areas.
Jeanne Bolger, MB BCh | Vice President, Venture Investments, Johnson & Johnson Development Corporation
Jeanne joined Johnson & Johnson Development Corporation (JJDC) as Vice President, Venture Investments, in February 2013. She is based in London, UK at the Johnson & Johnson Innovation Centre. Jeanne’s responsibilities are focused on investing in and managing portfolio investments in the pharmaceuticals and biotechnology areas in Europe.
Jeanne has over 25 years of pharmaceutical industry experience in management roles across R+D, Commercial and Business Development. She spent 11 years in Licensing and Acquisition, most recently as Global Head of Scientific Licensing for Johnson & Johnson’s Pharmaceutical business, having joined the Johnson & Johnson Family of Companies in 2005 from the Business Development group at GSK.
In 2009, Jeanne became VP Alliance Management and Board Director at Janssen Alzheimer Immunotherapy, working with Pfizer and Elan on immunotherapies targeting beta amyloid for Alzheimer’s disease.
Jeanne received her medical degree from University College Dublin. She also holds diplomas in Child Health (NUI) and in Finance and Accounting (ACCA). She is a Fellow of the Royal Academy of Medicine of Ireland (RAMI). She has served as the sole pharmaceutical industry representative on two Irish government taskforces seeking to enhance the commercialization of IP from Irish academic centres. She is a visiting lecturer on the MSc Pharmaceutical Medicine curriculum at Trinity College in Dublin, Ireland.
Also speaking :
- Alain Huriez | Manager, Advent Life Sciences
- Henrijette Richter | Partner, Sofinnova
19:00 | Registration Opens and Networking (Light Food & Beverages)
19:30 | Presentation
20:30 | Q&A
21:00 | Programme Close